Month: April 2021

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — Magic MergeCo, Inc. (the “Purchaser”), an entity controlled by funds (the “Apollo Funds”) managed by affiliates of Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”), a leading global alternative investment manager, and The Michaels Companies, Inc. (“Michaels”) (Nasdaq: MIK) today announced an agreement to extend the offering period of the previously commenced cash tender offer by the Purchaser to purchase all of the issued and outstanding shares of common stock of Michaels to 5:00 P.M., New York City time, on April 14, 2021, unless further extended. The tender offer was previously scheduled to expire one minute after 11:59 P.M., New York City time, on April 12, 2021. Computershare Trust Company, N.A., the depositary for the tender offer,...

BASEL, Switzerland, April 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need, today announced the pricing of its initial public offering of 7,500,000 ordinary shares at a public offering price of $17.00 per share. The gross proceeds to Vectiv, before deducting underwriting discounts and commissions and offering expenses, are expected to be $127.5 million. All of the ordinary shares are being offered by Vectiv. In addition, Vectiv has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ordinary shares at the initial public offering price, less the underwriting...

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $93.8 million, before deducting underwriting discounts and commissions and offering expenses. All of the shares are being offered by Reneo. The shares are expected to begin trading on the Nasdaq Global Market on April 9, 2021 under the symbol “RPHM.” In addition, Reneo has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock at the public offering price less underwriting...

New York, New York, April 08, 2021 (GLOBE NEWSWIRE) — Global SPAC Partners Co. (“Global” or the “Company”) (NASDAQ: GLSPU) announced today that it priced its initial public offering of 16,000,000 units, at $10.00 per unit. The units will be listed on the NASDAQ Capital Market (“NASDAQ”) and will begin trading tomorrow, April 9, 2021, under the ticker symbol “GLSPU.” Each unit consists of one subunit and one-half of a redeemable warrant.  Each subunit consists of one Class A ordinary share and one-quarter of a redeemable warrant. Each full warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the subunits and warrants are expected to be listed on NASDAQ under the symbols “GLSPT” and “GLSPW,” respectively.  Assuming...

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that the date by which SVX has to consummate its qualifying transaction is extended to August 31, 2021 (the “Extension”). On January 26, 2021, SVX announced its qualifying transaction to combine with InterCure Ltd. (dba Canndoc) (TASE: INCR), Israel’s leading cannabis company (the “Business Combination”). Canndoc, a wholly owned subsidiary of InterCure Ltd., is Israel’s largest licensed cannabis producer. On April 6, 2021, unitholders approved the Business Combination, with over 89.36% of the votes cast in favour of the plan of arrangement (the “Plan of Arrangement”) pursuant to which the Business Combination will be effected. On April 7, 2021, SVX obtained the final order of the British Columbia Supreme...

HONG KONG, April 08, 2021 (GLOBE NEWSWIRE) — Bonso Electronics International, Inc. (NASDAQ: BNSO and Company) today announced that it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the Nasdaq Listing Rules (the “Rules”) as a result of not having held an annual meeting of stockholders within 12 months of the end of the Company’s fiscal year on March 31, 2020. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Notice states that, under the Rules, the Company has 45 calendar days to submit a plan to regain compliance with...

加州爱莫利维尔, April 09, 2021 (GLOBE NEWSWIRE) — 今天，数字细胞生物学领域的龙头企业Berkeley Lights, Inc.（纳斯达克股票代码: BLI）宣布推出Opto Assure，这是细胞系开发前期提供产量和产品质量数据的一系列分析方法。第一个系列可直接检测产品总量，通过在抗体治疗开发过程中尽早评估生物治疗蛋白质的质量，确保快速推进批量生产。通过Opto Assure，客户可快速选择具有良好可制造性配置的克隆细胞系列，从而降低扩容成本，并改善下游产品。 随着复杂抗体治疗方式的出现，细胞系开发变得更具挑战性。这些精心设计的蛋白质容易出现质量问题（包括聚合、副产品和转化后的修饰），这些问题会影响药物的可制造性、保质期和安全性。Berkeley Lights在克隆选择过程中超越了效价评估，从而巩固了其在细胞系开发方面的技术领导地位。通过早期识别出具有高产量和所需质量的秘密产品克隆细胞，Opto Assure有助于最大限度地降低后期代价高昂的失效风险。 Berkeley Lights抗体疗法高级副总裁John Proctor博士说：“我们很高兴能够授权双特异性抗体等复杂疗法的制造商更快地开发更好的细胞系的生产。我们推出Opto Assure系列的目的是提高客户的生产能力，进一步减少用于防止下游产品失效的资源，并确保更加高效的工艺过程。” 关于Berkeley LightsBerkeley Lights是一家领先的数字细胞生物学公司，致力于促进和加速生物治疗剂及其他基于细胞的产品的快速开发和商业化。Berkeley Lights平台能同时捕获成千上万的单个细胞的深表型、功能型和基因型信息，能以最佳细胞形式为客户提供期望的活生物。我们的平台是一种全集成端对端解决方案，采用专有耗材，包括我们的OptoSelect™芯片和试剂套件、以及先进的自动化系统和应用软件。我们开发的Berkeley Lights平台可提供最先进的环境，确保上规模单细胞的快速功能特征化，其目标是在整个细胞类产品价值链中，为客户制定一种行业标准。 前瞻性声明鉴于本新闻稿中包含的声明不是对Berkeley...

No. 4/2021Copenhagen, 09 April 2021 Lauritz.com Group A/S is in the process of negotiating a sale of either (i) all the shares in Lauritz.com A/S, currently being negotiated as a sale to a newly formed holding company to be owned by a financial purchaser to become majority shareholder and Mette and Bengt Sundström to become substantial minority shareholders (the “Full Sale“) or (ii) its subsidiaries in Sweden, Germany and Finland to an industrial purchaser (the “Carve-out Sale“). The Full Sale is being negotiated with one party and the Carve-Out Sale is negotiated with another party. Lauritz.com A/S will initiate a written procedure tomorrow morning in which it seeks approval for both transactions from the holders of its senior secured bonds with ISIN SE0005999521. Full Sale The Full Sale would result in a full...

LE PRÉSENT COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION DES ÉTATS-UNIS NI DIFFUSÉ AUX ÉTATS-UNIS MONTRÉAL, 08 avr. 2021 (GLOBE NEWSWIRE) — Le Fonds de placement immobilier BTB (TSX : BTB.UN) (« BTB » ou le « Fonds ») annonce aujourd’hui qu’il a conclu une entente avec un syndicat de preneurs fermes mené par la Financière Banque Nationale inc. (les « Preneurs Fermes ») en vue d’un placement public de 6 791 000 parts de fiducie (les « Parts »), sujet aux approbations règlementaires, sur la base d’une prise ferme au prix de 4,05 $ la Part pour un produit brut total d’environ 27,5 millions $. Le Fonds a convenu d’octroyer aux Preneurs Fermes des options leur permettant d’acquérir jusqu’à un maximum de 1 018 650 parts additionnelles au même prix que le placement, pouvant être levé en tout...